2018 Conference on Retroviruses and Opportunistic Infections*

March 4-7, 2018; Boston, Massachusetts
Get up to date on the latest HIV data with rapid Capsule Summaries, downloadable slidesets, and live, expert-led Webinars covering key studies from Boston.
Daniel R. Kuritzkes, MD
Chloe Orkin Photo
Chloe Orkin, MBChB, FRCP, MD

ClinicalThought

Should patients with advanced HIV disease be started on INSTI-based regimens?

Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Released: April 17, 2018

What do the latest clinical data show about giving rifampin with dolutegravir, bictegravir, or tenofovir alafenamide?

Daniel R. Kuritzkes, MD Released: April 27, 2018
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC.
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Educational grant provided by:
Gilead Sciences
Janssen Therapeutics
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue